Pharmacologic and hemodynamic mechanisms underlying the antianginal actions of verapamil
- 1 October 1982
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 50 (4) , 886-893
- https://doi.org/10.1016/0002-9149(82)91250-4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise.Circulation, 1982
- The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response.Circulation, 1981
- A Controlled Trial of Verapamil for Prinzmetal's Variant AnginaNew England Journal of Medicine, 1981
- PHARMACOLOGICAL EFFECTS ON CORONARY HAEMODYNAMICS: A COMPARATIVE STUDY BETWEEN ATENOLOL, VERAPAMIL, NIFEDIPINE AND CARBOCROMENActa Medica Scandinavica, 1981
- Therapeutic implications of slow-channel blockade in cardiocirculatory disorders.Circulation, 1980
- Effects of verapamil on myocardial performance in coronary disease.Circulation, 1979
- VerapamilDrugs, 1978
- Effects of intravenous verapamil on hemodynamics in patients with heart diseaseAmerican Heart Journal, 1977
- Quantitative coronary arteriography: estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation.Circulation, 1977
- CORONARY VASODILATORY AND CARDIAC ADRENERGIC BLOCKING EFFECTS OF IPROVERATRILCanadian Journal of Physiology and Pharmacology, 1965